DEEPAKNTR Q2 FY27 Guidance vs Delivery (DEEPAKNTR Management Mirror)

MIBK and MIBC Derivatives Commercialized in Q2 FY27, Meeting Jun'26 Qtr Commissioning Guidance

In the Sep'26 Qtr concall, management announced the successful commercialization of MIBK and MIBC downstream derivatives. This outcome met the earlier guidance from the Jun'26 Qtr concall, which had targeted project commissioning for August 2026, following the initial Mar'26 Qtr expectation of a late Q1 or early Q2 FY27 launch. Looking ahead, management noted that MIBK and MIBC have achieved REACH registration in the company's name, which is expected to enable participation in European export markets moving forward.